Get started
Author

Tanya Rapoz-D’Silva

Observed names: Tanya Rapoz D’Silva, Tanya Rapoz-D'Silva
ORCID: 0000-0001-7194-3522
Observed ORCID: 0000-0001-7194-3522
OpenAlex ID: A5009451690
Molecular, clinical, and therapeutic determinants of outcome in NPM1 -mutated AML
2024 · Jad Othman, Nicola Potter, et al. · Blood · 112
PDF
Anti-CCR9 chimeric antigen receptor T cells for T-cell acute lymphoblastic leukemia
2022 · Paul M. Maciocia, Patrycja A. Wawrzyniecka, et al. · Blood · 70
PDF
LMTK3 expression in breast cancer: association with tumor phenotype and clinical outcome
2011 · Justin Stebbing, Aleksandra Filipovic, et al. · Breast Cancer Research and Treatment · 44
EZH2 -Deficient T-cell Acute Lymphoblastic Leukemia Is Sensitized to CHK1 Inhibition through Enhanced Replication Stress
2020 · Theresa E. León, Tanya Rapoz-D'Silva, et al. · Cancer Discovery · 39
Focal deletions of a promoter tether activate the IRX3 oncogene in T-cell acute lymphoblastic leukemia
2024 · Sunniyat Rahman, Gianna Bloye, et al. · Blood · 10
PDF
Transcription factor cooperativity at a GATA3 tandem DNA sequence determines oncogenic enhancer-mediated activation
2025 · Joana R. Costa, Yang Li, et al. · Cell Reports · 5
Anti-CCR9 CAR-T Cells for T Acute Lymphoblastic Leukemia
2021 · Paul M Maciocia, Patrycja Wawrzyniecka, et al. · Blood · 2
Correction: EZH2 -Deficient T-Cell Acute Lymphoblastic Leukemia is Sensitized to CHK1 Inhibition Through Enhanced Replication Stress
2026 · Theresa E. León, Tanya Rapoz-D’Silva, et al. · Cancer Discovery
PDF
Protocol to establish endogenous knockins in Jurkat T-ALL cells using CRISPR-Cas9-mediated homology-directed repair
2026 · Joana R. Costa, Yang Li, et al. · STAR Protocols
MYC-induced oncogenesis is dependent on acidic patches within its N-terminal intrinsically disordered domain
2025 · Victor Llombart, David O’Connor, et al. · bioRxiv (Cold Spring Harbor Laboratory)
Supplementary Figures and Legends from EZH2-Deficient T-cell Acute Lymphoblastic Leukemia Is Sensitized to CHK1 Inhibition through Enhanced Replication Stress
2023 · Theresa E. León, Tanya Rapoz-D'Silva, et al.
Supplementary Table 1 from EZH2-Deficient T-cell Acute Lymphoblastic Leukemia Is Sensitized to CHK1 Inhibition through Enhanced Replication Stress
2023 · Theresa E. León, Tanya Rapoz-D'Silva, et al.
Supplementary information from EZH2-Deficient T-cell Acute Lymphoblastic Leukemia Is Sensitized to CHK1 Inhibition through Enhanced Replication Stress
2023 · Theresa E. León, Tanya Rapoz-D'Silva, et al.
Supplementary Table 3 from EZH2-Deficient T-cell Acute Lymphoblastic Leukemia Is Sensitized to CHK1 Inhibition through Enhanced Replication Stress
2023 · Theresa E. León, Tanya Rapoz-D'Silva, et al.
Supplementary Table 2 from EZH2-Deficient T-cell Acute Lymphoblastic Leukemia Is Sensitized to CHK1 Inhibition through Enhanced Replication Stress
2023 · Theresa E. León, Tanya Rapoz-D'Silva, et al.
Data from EZH2-Deficient T-cell Acute Lymphoblastic Leukemia Is Sensitized to CHK1 Inhibition through Enhanced Replication Stress
2023 · Theresa E. León, Tanya Rapoz-D'Silva, et al.
Supplementary information from EZH2-Deficient T-cell Acute Lymphoblastic Leukemia Is Sensitized to CHK1 Inhibition through Enhanced Replication Stress
2023 · Theresa E. León, Tanya Rapoz-D'Silva, et al.
Data from EZH2-Deficient T-cell Acute Lymphoblastic Leukemia Is Sensitized to CHK1 Inhibition through Enhanced Replication Stress
2023 · Theresa E. León, Tanya Rapoz-D'Silva, et al.
The Hematopoietic Transcription Factor GATA3 Is the Main Activator of Enhancer-Mediated Activation of Oncogenic TAL1 in T-ALL
2022 · Joana R Costa, David O'Connor, et al. · Blood
Works count: 19
Citation count: 282
H-index: 5
I10-index: 5
Year
Topic
Type